Vitamin D Supplementation and Melanoma Incidence and Recurrence: A Meta-analysis of Randomized Controlled Trials

Clicks: 7
ID: 329233
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #202 of 216 articles by views in clinical and experimental dermatology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 216 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Vitamin D has been hypothesized to influence melanoma risk and progression, but observational findings are confounded by ultraviolet exposure. Objectives To assess the effect of vitamin D supplementation on melanoma recurrence and melanoma incidence using randomized controlled trial (RCT) evidence. Methods A PRISMA-guided systematic review and meta-analysis identified RCTs evaluating oral vitamin D supplementation, with or without calcium, reporting melanoma incidence or recurrence. Hazard ratios (HRs) were pooled for recurrence and relative risks (RRs) for incidence using random-effects models with the Hartung–Knapp–Sidik–Jonkman (HKSJ) correction. Results Five RCTs including 56,901 participants met inclusion criteria. Vitamin D supplementation was not associated with reduced melanoma recurrence (pooled HR 1.23; 95% CI 0.29–5.18; HKSJ-adjusted) or melanoma incidence (pooled RR 0.94; 95% CI 0.71–1.24; HKSJ-adjusted). Findings were consistent across varied dosing regimens and follow-up durations. Limitations Melanoma was a secondary endpoint in some trials, event rates were low, and dosing regimens varied. Conclusions Current randomized evidence does not support vitamin D supplementation as a strategy to reduce melanoma incidence or recurrence.
Reference Key
openalex_W7213965914 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Christian Roberti, Savannah Chapman, Hannah Jenkins, John Paul Lemchak, Margaret Mueller
Journal clinical and experimental dermatology
Year 2026
DOI
10.1093/ced/llag418
URL
https://doi.org/10.1093/ced/llag418
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.